Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Larry Ellison, the billionaire founder of database behemoth Oracle, more and more resembles a villain out of a science ...

Oracle founder Larry Ellison said the massive artificial intelligence ... "And you can make that vaccine, that mRNA vaccine, you can make that robotically again using AI in about 48 hours." US CEOS ...

Moderna (MRNA) stock surged 7% this week following Oracle (ORCL) CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer.

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early ...

Billionaire Larry Ellison’s backing of Stargate ... them against that cancer. That mRNA vaccine, you can make that robotically, again using AI, in about 48 hours.” The Ellison family ...

Larry Ellison of Oracle and also included Microsoft, NVIDIA and more. "A new American company that will invest $500 billion, at least, in AI infrastructure in the United States, creating over ...

Moderna shares are rising after Oracle’s Larry Ellison highlights AI’s ... cancer genes to create personalized mRNA vaccines. He claimed AI-driven automation could enable the production ...

Oracle founder Larry Ellison said the massive artificial ... "And you can make that vaccine, that mRNA vaccine, you can make that robotically again using AI in about 48 hours." ...

Oracle Chairman Larry Ellison highlights AI's potential ... according to Economic Times. Using AI-driven automation, such mRNA vaccines could be produced robotically within 48 hours, significantly ...